OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Core functional nodes and sex-specific pathways in human ischaemic and dilated cardiomyopathy
Mengbo Li, Benjamin L. Parker, Evangeline Pearson, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 68

Showing 1-25 of 68 citing articles:

Small molecule metabolites: discovery of biomarkers and therapeutic targets
Shi Qiu, Ying Cai, Hong Yao, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 361

Gut microbiota impact on the peripheral immune response in non-alcoholic fatty liver disease related hepatocellular carcinoma
Jason Behary, Nadia Amorim, Xiaotao Jiang, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 313

Sex-Specific Control of Human Heart Maturation by the Progesterone Receptor
Choon Boon Sim, Belinda Phipson, Mark Ziemann, et al.
Circulation (2021) Vol. 143, Iss. 16, pp. 1614-1628
Open Access | Times Cited: 67

Extracellular Matrix in Heart Failure: Role of ADAMTS5 in Proteoglycan Remodeling
Javier Barallobre‐Barreiro, Tamás Radovits, Marika Fava, et al.
Circulation (2021) Vol. 144, Iss. 25, pp. 2021-2034
Open Access | Times Cited: 61

Sex‐Related Differences in Genetic Cardiomyopathies
Alessia Argirò, Carolyn Y. Ho, Sharlene M. Day, et al.
Journal of the American Heart Association (2022) Vol. 11, Iss. 9
Open Access | Times Cited: 39

LncRNA CHKB-DT Downregulation Enhances Dilated Cardiomyopathy Through ALDH2
Xiang Nie, Jiahui Fan, Dai B, et al.
Circulation Research (2024) Vol. 134, Iss. 4, pp. 425-441
Open Access | Times Cited: 14

Lipotoxicity as a therapeutic target in obesity and diabetic cardiomyopathy
Michinari Nakamura
Journal of Pharmacy & Pharmaceutical Sciences (2024) Vol. 27
Open Access | Times Cited: 13

The Efficacy of Risk Factor Modification Compared to NAD+ Repletion in Diastolic Heart Failure
Yen Chin Koay, Ren Ping Liu, Bailey McIntosh, et al.
JACC Basic to Translational Science (2024) Vol. 9, Iss. 6, pp. 733-750
Open Access | Times Cited: 6

Proteomics and phosphoproteomics of failing human left ventricle identifies dilated cardiomyopathy-associated phosphorylation of CTNNA3
Cristine J. Reitz, Marjan Tavassoli, Da Hye Kim, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 19
Open Access | Times Cited: 15

Lack of sexual dimorphism in a mouse model of isoproterenol-induced cardiac dysfunction
Marianne Grant, Ibrahim Y. Abdelgawad, Christine A. Lewis, et al.
PLoS ONE (2020) Vol. 15, Iss. 7, pp. e0232507-e0232507
Open Access | Times Cited: 34

Nuclear Tkt promotes ischemic heart failure via the cleaved Parp1/Aif axis
Zhiyan Wang, Zeping Qiu, Sha Hua, et al.
Basic Research in Cardiology (2022) Vol. 117, Iss. 1
Closed Access | Times Cited: 20

Integrated transcriptomic and regulatory RNA profiling reflects complex pathophysiology and uncovers a conserved gene signature in end stage heart failure
Amit Anand, Julius Punnen, U.M. Nagamalesh, et al.
Journal of Molecular and Cellular Cardiology Plus (2025) Vol. 11, pp. 100282-100282
Open Access

Dilated Cardiomyopathy Signature Metabolic Marker Screening: Machine Learning and Multi-omics Analysis
Xiaolei Li, Aibibanmu Aizezi, Yanpeng Li, et al.
Heliyon (2025) Vol. 11, Iss. 3, pp. e41927-e41927
Open Access

Heterogeneous effects of genetic variants and traits associated with fasting insulin on cardiometabolic outcomes
Magdalena Sevilla-González, Kirk Smith, N. Wang, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access

Integrating -Omic Technologies across Modality, Space, and Time to Decipher Remodeling in Cardiac Disease
John F. Mulvey, Esther Meyer, Mikkel Skjoldan Svenningsen, et al.
Current Cardiology Reports (2025) Vol. 27, Iss. 1
Open Access

Integrated liver-secreted and plasma proteomics identify a predictive model that stratifies MASH
William De Nardo, Olivia W. Lee, Yazmin Johari, et al.
Cell Reports Medicine (2025), pp. 102085-102085
Open Access

Microbial metabolites associated in stool and left ventricle of heart failure patients revealed by meta-analysis
Emily Wissel, Hsin-Yuan Chien, Ke-Hsuan Wei, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access

Multi‐omic analyses and network biology in cardiovascular disease
Cristine J. Reitz, Uroš Kuzmanov, Anthony O. Gramolini
PROTEOMICS (2023) Vol. 23, Iss. 21-22
Open Access | Times Cited: 10

Integrative Proteomic Analysis Reveals the Cytoskeleton Regulation and Mitophagy Difference Between Ischemic Cardiomyopathy and Dilated Cardiomyopathy
Muyin Liu, Linhui Zhai, Zhaohua Yang, et al.
Molecular & Cellular Proteomics (2023) Vol. 22, Iss. 12, pp. 100667-100667
Open Access | Times Cited: 10

Network-based identification of diagnosis-specific trans-omic biomarkers via integration of multiple omics data
Md Mamunur Rashid, Momoko Hamano, Midori Iida, et al.
Biosystems (2024) Vol. 236, pp. 105122-105122
Closed Access | Times Cited: 3

Integrative Proteomic and Metabolomic Elucidation of Cardiomyopathy with in vivo, in vitro Models and Clinical Samples
Yiwei Hu, Yunzeng Zou, Liang Qiao, et al.
Molecular Therapy (2024) Vol. 32, Iss. 10, pp. 3288-3312
Closed Access | Times Cited: 3

Characteristics of Blood Metabolic Profile in Coronary Heart Disease, Dilated Cardiomyopathy and Valvular Heart Disease Induced Heart Failure
Chang Liu, Ruihua Li, Yang Liu, et al.
Frontiers in Cardiovascular Medicine (2021) Vol. 7
Open Access | Times Cited: 22

Page 1 - Next Page

Scroll to top